Literature DB >> 19492341

Thermodynamic stability assessment of a colloidal iron drug product: sodium ferric gluconate.

Yongsheng Yang1, Rakhi B Shah, Patrick J Faustino, Andre Raw, Lawrence X Yu, Mansoor A Khan.   

Abstract

A high performance gel permeation chromatography (HP-GPC) method was developed, validated and used to determine the molecular weight (MW) of sodium ferric gluconate following various stress conditions. The intra-day accuracy (90-103%), intra-day precision (1.5-2.7%), inter-day accuracy (91-105%), inter-day precision (1.3-3.2%) were within acceptable range stated in FDA guidance. The MW of sodium ferric gluconate remained unchanged after: (1) autoclaving (121 degrees C), (2) moderate thermal stress (30 days at 50 degrees C or 7 days at 70 and 90 degrees C), (3) excipient dilution, (4) basic buffer dilution (pH of 8 and 9), (5) ultracentrifugation, (6) dialysis, and (7) electrolyte dilution. However sodium ferric gluconate showed signs of instability at higher temperatures (>90 degrees C) after 30 days and at pH of 10-11. Sodium ferric gluconate was found to be a lypophilic colloidal solution with an average particle size of 10 nm and a zeta potential of -13 mV. The colloid osmotic pressure was 3.5 mmHg and remained unchanged after moderate thermal stress. Additionally, in-house drug products with similar MW to sodium ferric gluconate were produced by three different synthetic procedures, suggesting that this colloidal iron drug product might be thermodynamically stable.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19492341     DOI: 10.1002/jps.21806

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

Review 1.  How Has CDER Prepared for the Nano Revolution? A Review of Risk Assessment, Regulatory Research, and Guidance Activities.

Authors:  Katherine M Tyner; Nan Zheng; Stephanie Choi; Xiaoming Xu; Peng Zou; Wenlei Jiang; Changning Guo; Celia N Cruz
Journal:  AAPS J       Date:  2017-04-18       Impact factor: 4.009

Review 2.  Scientific and Regulatory Considerations for Generic Complex Drug Products Containing Nanomaterials.

Authors:  Nan Zheng; Dajun D Sun; Peng Zou; Wenlei Jiang
Journal:  AAPS J       Date:  2017-01-23       Impact factor: 4.009

3.  Snapshots of Iron Speciation: Tracking the Fate of Iron Nanoparticle Drugs via a Liquid Chromatography-Inductively Coupled Plasma-Mass Spectrometric Approach.

Authors:  Heather M Neu; Sergei A Alexishin; Joel E P Brandis; Anne M C Williams; Wenjing Li; Dajun Sun; Nan Zheng; Wenlei Jiang; Ann Zimrin; Jeffrey C Fink; James E Polli; Maureen A Kane; Sarah L J Michel
Journal:  Mol Pharm       Date:  2019-02-14       Impact factor: 4.939

Review 4.  Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products.

Authors:  Peng Zou; Katherine Tyner; Andre Raw; Sau Lee
Journal:  AAPS J       Date:  2017-07-31       Impact factor: 4.009

5.  In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations.

Authors:  Amy Barton Pai; Manjunath P Pai; Dan E Meyer; Brian C Bales; Victoria E Cotero; Nan Zheng; Wenlei Jiang
Journal:  Regul Toxicol Pharmacol       Date:  2018-05-29       Impact factor: 3.271

6.  Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.

Authors:  Joel E P Brandis; Kyle C Kihn; Marc B Taraban; Julia Schnorr; Alex M Confer; Sharon Batelu; Dajun Sun; Jason D Rodriguez; Wenlei Jiang; David P Goldberg; Peter Langguth; Timothy L Stemmler; Yihua Bruce Yu; Maureen A Kane; James E Polli; Sarah L J Michel
Journal:  Mol Pharm       Date:  2021-02-23       Impact factor: 5.364

7.  Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Physicochemical Characterization.

Authors:  Dajun Sun; Rodney Rouse; Vikram Patel; Yong Wu; Jiwen Zheng; Alokita Karmakar; Anil K Patri; Priyanka Chitranshi; David Keire; Jia Ma; Wenlei Jiang
Journal:  Nanomaterials (Basel)       Date:  2018-01-05       Impact factor: 5.076

8.  Performance of Redox Active and Chelatable Iron Assays to Determine Labile Iron Release From Intravenous Iron Formulations.

Authors:  A B Pai; D E Meyer; B C Bales; V E Cotero; M P Pai; N Zheng; W Jiang
Journal:  Clin Transl Sci       Date:  2017-02-03       Impact factor: 4.689

9.  Pharmaceutical stability of colloidal saccharated iron oxide injection in normal saline.

Authors:  Daiki Hira; Asami Suzuki; Yusuke Kono; Kosuke Shimokawa; Serika Matsuoka; Ken-Yuh Hasumoto; Hiroyuki Kawahara; Masahide Onoue; Takuya Fujita; Tomonobu Okano; Mikio Kakumoto
Journal:  J Pharm Health Care Sci       Date:  2018-07-25

Review 10.  Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics.

Authors:  Felix Funk; Beat Flühmann; Amy E Barton
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.